One Kit To Test For 20 Diseases In 20 Minutes

A*STAR and One BioMed have established joint lab to develop a diagnostic kit that can rapidly diagnose a range of infectious diseases.

Promising Phase 3 Results For Green Valley’s Alzheimer’s Drug

The marine-derived compound GV-971 was found to be safe and effective for treating mild-to-moderate Alzheimer’s disease.

WuXi And CECD Join Forces To Create Big Data Solutions For Healthcare

The joint venture will use big data, cloud computing and artificial intelligence to advance research in healthcare and pharmaceuticals.

WuXi AppTec Launches Drug Screening Library

The DNA-Encoded Library platform consists of 80 billion unique molecules which are structurally diverse and chemically exclusive.

US FDA Approves Anti-Epileptic Drug For Kids

Fycompa is now cleared for use in patients four years of age and older with partial-onset seizures.

Merck Opens US$15 Million Lab In Singapore

The M Lab Collaboration Center will recreate actual manufacturing conditions for biologics and enhance biosafety testing.

China Approves Home-Grown Colon Cancer Drug

Fruquintinib is the first drug discovered and developed in China to be approved by the National Medical Products Administration.

US FDA Approves LENVIMA For Unresectable Liver Cancer

Lenvatinib mesylate was shown to improve overall survival in patients with unresectable liver cancer.

Lion TCR’s T-Cell Therapy Gets Phase I/II Trial Approval

Singapore’s Health Sciences Authority has approved Lion TCR’s Phase I/II clinical study of immunotherapy for liver cancer.